Robert P Venuti Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

10/2020

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Venuti Research Topics

Disease

2	Heart Failure 01/2019 - 10/2017
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Diarrhea 10/2020
1	Neoplasms (Cancer) 10/2020
1	Pulmonary Embolism 10/2020
1	Myalgia 10/2020
1	Headache (Headaches) 01/2019
1	Cardiac Arrhythmias (Arrythmia) 10/2017
1	Hypotension (Low Blood Pressure) 10/2017

Drug/Important Bio-Agent (IBA)

2	nitroxylIBA 01/2019 - 10/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 10/2017
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2020
1	Estrogen ReceptorsIBA 10/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020
1	Hormones (Hormone)IBA 10/2020
1	NitrogenIBA 01/2019

Therapy/Procedure

1	Therapeutics 10/2020